Research Topics
| Deborah KubanSummaryAffiliation: The University of Texas Country: USA Publications
| Collaborators
|
Detail Information
Publications
High-dose intensity modulated radiation therapy for prostate cancerDeborah A Kuban
Department of Radiation Oncology, M D Anderson Cancer Center, 1515 Holcombe Blvd, Box 97, Houston, TX 77007, USA
Curr Urol Rep 5:197-202. 2004..This technique continues to evolve, working toward image-guided radiation therapy, which is adjusted daily for positional and architectural changes of the gland...
Comparison of biochemical failure definitions for permanent prostate brachytherapyDeborah A Kuban
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 65:1487-93. 2006..To assess prostate-specific antigen (PSA) failure definitions for patients with Stage T1-T2 prostate cancer treated by permanent prostate brachytherapy...
Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancerDeborah A Kuban
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 70:67-74. 2008..To report the long-term results of a randomized radiotherapy dose escalation trial for prostate cancer...
Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA eraDeborah A Kuban
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
Int J Radiat Oncol Biol Phys 57:915-28. 2003..To report the long-term outcome for patients with Stage T1-T2 adenocarcinoma of the prostate definitively irradiated in the prostate-specific antigen (PSA) era...
Hazards of dose escalation in prostate cancer radiotherapyDeborah Kuban
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 57:1260-8. 2003..To assess the benefit of escalating the dose in definitive prostate cancer radiotherapy vs. the associated risk of complications...
Radiation for prostate cancer: use of biochemical failure as an endpoint following radiotherapyDeborah A Kuban
Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Box 97, TX 77030, Houston, USA
World J Urol 21:253-64. 2003..A summary of these results and the associated issues are presented here...
Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?Deborah A Kuban
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 79:1310-7. 2011..To report long-term failure patterns and survival in a randomized radiotherapy dose escalation trial for prostate cancer...
PSA after radiation for prostate cancerDeborah A Kuban
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77007, USA
Oncology (Williston Park) 18:595-604; discussion 605, 609. 2004..The concept of a universal definition of failure that might be applied to multiple modalities, including surgery, should also be investigated, at least for comparative study and research purposes...
Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all?Deborah Kuban
Department of Radiation Oncology, MD Anderson Cancer Center Orlando, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 61:409-14. 2005..To compare long-term outcome using alternative failure definitions after external beam radiation for localized prostate cancer...
Ultrasound-based localizationDeborah A Kuban
Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, TX, USA
Semin Radiat Oncol 15:180-91. 2005..For breast cancer radiotherapy, ultrasound serves to define involved primary and nodal sites, especially in patients in whom surgical evaluation will not be the first therapeutic step...
Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995Patrick Kupelian
Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
Int J Radiat Oncol Biol Phys 61:415-9. 2005..To study the radiation dose-response as determined by Kaplan-Meier prostate-specific antigen (PSA) disease-free survival (PSA-DFS) estimates in patients with stage T1-T2 prostate cancer treated within a 2-year period (1994-1995)...
The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995Howard D Thames
Division of Quantitative Sciences, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Radiother Oncol 96:6-12. 2010..Assess the importance of overall time (OT) and dose for biochemical failure (BF) after external-beam radiotherapy of prostate cancer in a retrospective analysis of a nine-institution database with 4839 patients...
Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995Howard Thames
Department of Biomathematics, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
Int J Radiat Oncol Biol Phys 57:929-43. 2003....
Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapySusan L Tucker
Department of Biostatistics and Applied Mathematics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 60:1589-601. 2004..To compare the fits of normal-tissue complication probability (NTCP) models based on rectal dose-wall histograms (DWHs) vs. dose-volume histograms (DVHs) when the two are used to analyze a common set of late rectal toxicity data...
Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancerM Rex Cheung
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
Int J Radiat Oncol Biol Phys 67:1059-65. 2007..We sought to identify the bladder dose-volume factors associated with an increased risk of late urinary toxicity among prostate cancer patients treated with radiotherapy...
Dose-volume response analyses of late rectal bleeding after radiotherapy for prostate cancerSusan L Tucker
Department of Biostatistics and Applied Mathematics, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 59:353-65. 2004..To compare the fits of various normal tissue complication probability (NTCP) models to a common set of late rectal toxicity data, with the aim of identifying the best model for predicting late rectal injury after irradiation...
An automatic CT-guided adaptive radiation therapy technique by online modification of multileaf collimator leaf positions for prostate cancerLaurence E Court
Department of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 62:154-63. 2005....
Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA eraPatrick Kupelian
Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
Int J Radiat Oncol Biol Phys 63:795-9. 2005..Accounting for these changes would facilitate the retrospective comparison of outcomes for patients treated in different periods...
Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapyRex Cheung
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 63:134-40. 2005..By comparing the outcomes for patients who received RT alone and for those who received combined RT and hormonal therapy, we assessed the potential benefits of hormonal therapy...
Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapyMary Feng
Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109 0010, USA
Int J Radiat Oncol Biol Phys 68:1417-23. 2007..To determine the rate and magnitude of late genitourinary (GU) and gastrointestinal (GI) toxicities after salvage or adjuvant radiotherapy (RT) for prostate cancer, and to determine predictive factors for these toxicities...
Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman modelSusan L Tucker
Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 1402, USA
Int J Radiat Oncol Biol Phys 78:1253-60. 2010....
Cluster model analysis of late rectal bleeding after IMRT of prostate cancer: a case-control studySusan L Tucker
Department of Biostatistics and Applied Mathematics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 64:1255-64. 2006..The purpose of this study was to test the validity of a two-dimensional cluster model of late rectal toxicity based on maximum cluster size of damage to rectal surface...
Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapyRex Cheung
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Box 97, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 61:993-1002. 2005..We also investigated the differences in the dose-response characteristics using the American Society for Therapeutic Radiology and Oncology (ASTRO) definition vs. an alternative biochemical failure definition...
Use of deformed intensity distributions for on-line modification of image-guided IMRT to account for interfractional anatomic changesRadhe Mohan
Department of Radiation Physics, Unit 94, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 61:1258-66. 2005..In this paper, we report the development of one such intermediate method that takes into account anatomic changes by deforming the intensity distributions of each beam based on deformations of anatomy as seen in the beam's-eye-view...
Prostate-specific antigen doubling time predicts clinical outcome and survival in prostate cancer patients treated with combined radiation and hormone therapyAndrew K Lee
Division of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 63:456-62. 2005..To determine whether prostate-specific antigen (PSA) doubling time predicts clinical outcomes in patients with prostate cancer that has been treated with combined radiation and hormone therapy...
Comparison of treatment volumes and techniques in prostate cancer radiation therapyCatherine T Lee
Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
Am J Clin Oncol 28:618-25. 2005..Because dose-volume parameters have been shown to relate to toxicity, IMRT would appear to be the favored technique for prostate cancer radiation, particularly with regard to nodal treatment...
Dosimetric comparison of four target alignment methods for prostate cancer radiotherapyLei Dong
Department of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 66:883-91. 2006..CT-guided alignment provided the best and most consistent dosimetric coverage. A larger planning target volume margin is needed for SV coverage when the alignment target is the prostate...
Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancerRex Cheung
Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 58:1513-9. 2004..This study analyzed the utility and limitations of the widely used Lyman-Kutcher- Burman (LKB) normal tissue complication probability model in projecting the hazards of rectal complication with high-dose RT...
Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with external beam radiationCharles J Rosser
Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
J Urol 168:536-41. 2002..CONCLUSIONS: Men with prostate cancer who are 60 years or younger and treated with radiotherapy may be at significant risk for long-term biochemical failure...
Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapyRenaud de Crevoisier
Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 62:965-73. 2005..Therefore, an empty rectum is warranted at the time of simulation. These results also emphasize the need for image-guided radiotherapy to improve local control in irradiating prostate cancer...
PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysisMichael E Ray
Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109 0010, USA
Int J Radiat Oncol Biol Phys 64:1140-50. 2006....
Hazard rates of disease progression after external beam radiotherapy for clinically localized carcinoma of the prostateCharles J Rosser
Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
J Urol 169:2160-5. 2003..Patients are at slight but persistent risk for biochemical failure more than 5 years after treatment. Hazard rate calculations beyond the median followup of 4 years can underestimate the true hazard...
Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trialAlan Pollack
Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, TX, USA
Int J Radiat Oncol Biol Phys 54:677-85. 2002..These issues were investigated in a cohort of men with Stage T1-T3 prostate cancer who were randomized to receive between 70 Gy and 78 Gy and were prospectively biopsied at about 2 years after the completion of radiotherapy (RT)...
Dose-response for biochemical control among high-risk prostate cancer patients after external beam radiotherapyRex Cheung
Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Boulevard, Box 97, Houston, TX 77030-4009, USA
Int J Radiat Oncol Biol Phys 56:1234-40. 2003..There is a steep dose response in PSA control probability around a modern dose of 78 Gy. A 5-Gy dose increase beyond 78 Gy may improve PSA control by about 10%...
Evaluation of a contour-alignment technique for CT-guided prostate radiotherapy: an intra- and interobserver studyLaurence E Court
Department of Radiation Physics, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA
Int J Radiat Oncol Biol Phys 59:412-8. 2004..The use of a reference image is important to improve the consistency among different users in this technique...
Use of portal images and BAT ultrasonography to measure setup error and organ motion for prostate IMRT: implications for treatment marginsDarren J Little
Department of Radiation Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 56:1218-24. 2003..Relatively large planning target volume margins in the AP and SI dimensions may be necessary to overcome this...
Experience of ultrasound-based daily prostate localizationAnurag Chandra
Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 56:436-47. 2003..Although the accuracy of the BAT was not addressed in this investigation, we found a significant percentage of large shifts being made from the initial alignment position...
Defining recurrence after radiation for prostate cancerDeborah A Kuban
Department of Radiation Oncology and Biostatistics, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
J Urol 173:1871-8. 2005..The application of a universal PSA definition of tumor recurrence across multiple treatment modalities should also be explored...
Utility of the percentage of positive prostate biopsies in predicting PSA outcome after radiotherapy for patients with clinically localized prostate cancerUgur Selek
Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA
Int J Radiat Oncol Biol Phys 57:963-7. 2003..CONCLUSION: PPPB was a predictor of post-external beam radiotherapy PSA outcome in clinically localized prostate cancer; but in this cohort it did not provide additional information beyond the traditional risk stratification schema...
Changes in the pelvic anatomy after an IMRT treatment fraction of prostate cancerRenaud de Crevoisier
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 68:1529-36. 2007..To quantify the three-dimensional variations of pelvic anatomy after a single treatment fraction...
Daily bone alignment with limited repeat CT correction rivals daily ultrasound alignment for prostate radiotherapyJennifer C O'Daniel
Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 71:274-80. 2008....
Stage T1c prostate cancer: a heterogeneous category with widely varying prognosisArthur Y Hung
Department of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer J 8:440-4. 2002..Improvement in prostate imaging and multiple core biopsies may be helpful in better defining the extent of disease in the individual patient...
Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancerEugene H Huang
Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Int J Radiat Oncol Biol Phys 54:1314-21. 2002..Therefore, dose escalation may be safely achieved by adherence to dose-volume histogram constraints during treatment planning and organ localization at the time of treatment to ensure consistent patient setup...
Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapyStephen F Kry
Department of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 62:1204-16. 2005..This information is useful in determining the dose to critical structures and in evaluating the risk of associated carcinogenesis...
Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantationMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 67:327-33. 2007..To assess long-term prostate-specific antigen (PSA) outcome after permanent prostate brachytherapy (BT) and identify predictors of improved disease-free survival...
Erectile dysfunction and radiation dose to penile base structures: a lack of correlationUgur Selek
Department of Radiation Oncology, Unit 97, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 59:1039-46. 2004..The entire etiology of radiation- induced erectile dysfunction remains unclear and further research is needed...
Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomyAshish M Kamat
Department of Urology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
J Urol 170:1860-3. 2003..9 ng/ml at presentation are at increased risk for recurrence after adjuvant RT...
Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysisEric M Horwitz
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
Cancer 107:1496-502. 2006....
Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancerSara S Strom
Department of Epidemiology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 107:631-9. 2006..The current study sought to determine whether obesity was an independent predictor of biochemical failure (BF) and clinical recurrence (CF) among patients treated with external-beam radiotherapy (EBRT)...
The predictive value of 2-year posttreatment biopsy after prostate cancer radiotherapy for eventual biochemical outcomeWaseet Vance
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 67:828-33. 2007..To determine the value of a 2-year post-radiotherapy (RT) prostate biopsy for predicting eventual biochemical failure in patients who were treated for localized prostate cancer...
Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancerCharles J Rosser
Department of Urology, The University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA
J Urol 168:2001-5. 2002..The PSA bounce phenomenon was not predictive of time to biochemical recurrence...
Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failureMichael E Ray
Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0010, USA
Urology 68:1257-62. 2006..To determine whether nadir prostate-specific antigen (PSA) levels within 12 months (nadir PSA12) after completion of radiotherapy (RT) can be used as an early marker of recurrence risk...
Quality-of-life questionnaire results 2 and 3 years after radiotherapy for prostate cancer in a randomized dose-escalation studyDarren J Little
Department of Radiation Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
Urology 62:707-13. 2003..Comparing the results 2 and 3 years after radiotherapy, the symptoms of rectal bleeding had improved, erectile function had decreased, and urinary urge incontinence had increased...
Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United StatesSteven J Frank
Department of Radiation Oncology, The University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
Brachytherapy 6:2-8. 2007..This study is aimed at understanding and defining the current patterns of care with respect to prostate brachytherapy for patients with intermediate-risk localized disease in the combined academic and community setting...
Is a loose-seed nomogram still valid for prostate brachytherapy in a stranded-seed era?Rajat J Kudchadker
Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
Int J Radiat Oncol Biol Phys 72:623-7. 2008..To characterize the amount of activity required to treat the prostate with stranded (125)I radioactive seeds and compare our stranded data with the amount of activity recommended when individual seeds are implanted using a Mick applicator...
Prostogram predicted brachytherapy outcomes are not universally accurate: an analysis based on the M. D. Anderson Cancer Center experience with (125)iodine brachytherapySteven J Frank
Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas, USA
J Urol 181:1658-63; discussion 1663-4. 2009..We examined whether the Prostogram accurately predicted recurrence at 5 years in patients treated with (125)I brachytherapy at 1 tertiary cancer center...
Uncertainty of calculated risk estimates for secondary malignancies after radiotherapyStephen F Kry
Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 68:1265-71. 2007..This work examines the uncertainty in absolute risk estimates and in the ratio of risk estimates between different treatment modalities...
Treatment-planning study of prostate cancer intensity-modulated radiotherapy with a Varian Clinac operated without a flattening filterOleg N Vassiliev
Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
Int J Radiat Oncol Biol Phys 68:1567-71. 2007....
Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatmentXiaodong Zhang
Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 67:620-9. 2007..To determine the dosimetric impact of interfraction anatomic movements in prostate cancer patients receiving proton therapy...
Quantification of prostate and seminal vesicle interfraction variation during IMRTSteven J Frank
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 71:813-20. 2008....
Ductal adenocarcinoma of the prostate: clinical features and implications after local therapyShi Ming Tu
Department of Genitourinary Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 115:2872-80. 2009..The authors of this report investigated the clinical outcome of patients who had prostate ductal adenocarcinoma after primary radical prostatectomy or radiotherapy...
A volumetric trend analysis of the prostate and seminal vesicles during a course of intensity-modulated radiation therapySteven J Frank
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Am J Clin Oncol 33:173-5. 2010....
An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancerSteven J Frank
Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
J Urol 177:2151-6; discussion 2156. 2007..Monotherapy with radical prostatectomy, high dose external beam radiotherapy or a (125)I implant is reported to produce equivalent outcomes. We assessed the health related quality of life associated with these 3 treatment approaches...
First-year PSA kinetics and minima after prostate cancer radiotherapy are predictive of overall survivalRex Cheung
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 66:20-4. 2006..We analyzed whether first-year prostate-specific antigen (PSA) kinetics and minima are predictive of overall survival (OS)...
Assessing the impact of an alternative biochemical failure definition on radiation dose response for high-risk prostate cancer treated with external beam radiotherapyRex Cheung
Departments of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 61:14-9. 2005..We assessed the effect of using an alternative failure definition on the dose-response characteristics of high-risk prostate cancer treated with radiotherapy alone...
Dosimetric consequences of using a surrogate urethra to estimate urethral dose after brachytherapy for prostate cancerHoon K Lee
Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA
Int J Radiat Oncol Biol Phys 57:355-61. 2003..An alternative position for a surrogate urethra accounting for the difference in the location of the Foley catheter near the base of the prostate at Day 0 and 1 month could be considered in future studies...
Symptomatic local recurrence of prostate carcinoma after radiation therapyDan Leibovici
Department of Urology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 103:2060-6. 2005..Aggressive histologic subtypes were predictive of this endpoint. Clinical T classification, Gleason score, and initial prostate-specific antigen levels also may have predictive value...
Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinomaCharles J Rosser
Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 56:1-6. 2003....
Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trialsKaren E Hoffman
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
J Urol 185:116-20. 2011....
The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapyStephen F Kry
Department of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 62:1195-203. 2005..Perhaps this risk should be considered when choosing the optimal treatment technique and delivery system for patients who will undergo prostate radiation...
Increasing external beam dose for T1-T2 prostate cancer: effect on risk groupsHoward D Thames
Department of Biostatistics and Applied Mathematics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, and Department of Radiation Oncology, William Beaumont Hospital, Deroit, MI, USA
Int J Radiat Oncol Biol Phys 65:975-81. 2006....
Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trialAlan Pollack
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
Int J Radiat Oncol Biol Phys 53:1097-105. 2002..A randomized radiotherapy dose escalation trial was undertaken between 1993 and 1998 to compare the efficacy of 70 vs. 78 Gy in controlling prostate cancer...
Impact of androgen deprivation therapy on survival in men treated with radiation for prostate cancerAlan Pollack
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
Urology 60:22-30; discussion 30-1. 2002..The results with long-term ADT are much more convincing than short-term ADT, and, as a consequence, 2 to 3 years are recommended...
Clinical features and treatment outcome of Hispanic men with prostate cancer following external beam radiotherapyCharles J Rosser
Department of Urology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
J Urol 170:1856-9. 2003..Improved screening and early detection may improve disease-free survival in Hispanic men with localized prostate cancer...
Intrafraction prostate motion during IMRT for prostate cancerEugene Huang
Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Int J Radiat Oncol Biol Phys 53:261-8. 2002..Intrafraction motion was much smaller than interfraction motion, and the two types of movement did not correlate...
The delivery of IMRT with a single physical modulator for multiple fields: a feasibility study for paranasal sinus cancerLei Dong
Department of Radiation Physics, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Int J Radiat Oncol Biol Phys 58:876-87. 2004..Clinics may find it worthwhile to commit the minimal extra time for quality assurance and treatment to benefit from the improved dose distribution and lack of interplay between MLC leaf motion and internal target motion...
Dose-volume conundrum for response of prostate cancer to brachytherapy: summary dosimetric measures and their relationship to tumor control probabilityWARREN D D'SOUZA
Department of Radiation Physics, University of Texas M D Anderson Cancer Center, Houston, TX, USA
Int J Radiat Oncol Biol Phys 58:1540-8. 2004..g., moderate underdosing of large volumes vs. extreme underdosing of small volumes)...
Performance evaluation of automatic anatomy segmentation algorithm on repeat or four-dimensional computed tomography images using deformable image registration methodHe Wang
Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009, USA
Int J Radiat Oncol Biol Phys 72:210-9. 2008..The goal of this study was to quantitatively evaluate the performance of the algorithm in typical clinical applications...
Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer?Adam D Melancon
Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, USA
Radiother Oncol 85:251-9. 2007....
Validation of an accelerated 'demons' algorithm for deformable image registration in radiation therapyHe Wang
Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
Phys Med Biol 50:2887-905. 2005..Together, these results suggest that the accelerated demons algorithm has significant potential for delineating and tracking doses in targets and critical structures during CT-guided radiotherapy...
Implementation and validation of a three-dimensional deformable registration algorithm for targeted prostate cancer radiotherapyHe Wang
Department of Radiation Physics, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 61:725-35. 2005..610 to 0.944 after registration of the two patient CT sets. CONCLUSION: The algorithm had an accuracy of about 1 mm. It could be used for optimizing dose calculation and delivery for prostate radiotherapy...
Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysisEric M Horwitz
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 2497, USA
J Urol 173:797-802. 2005..In this report we determined the sensitivity and specificity of several BF definitions using distant failure (DF) alone or clinical failure (CF), defined as local failure (LF) and/or DF...
Toward a real-time in vivo dosimetry system using plastic scintillation detectorsLouis Archambault
Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 78:280-7. 2010..In the present study, we have presented and validated a plastic scintillation detector (PSD) system designed for real-time multiprobe in vivo measurements...
Racial influence on biochemical disease-free survival in men treated with external-beam radiotherapy for localized prostate cancerCharles J Rosser
Department of Urology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
J Natl Med Assoc 96:939-44. 2004..Continued diligence in screening and early detection may improve prostate cancer outcome for other minority populations...
A multidisciplinary prostate cancer clinic for newly diagnosed patients: developing the role of the advanced practice nurseLydia T Madsen
Department of Genitourinary Medical Oncology, University of Texas, M D Anderson Cancer Center, Houston, TX, USA
Clin J Oncol Nurs 13:305-9. 2009..Formal evaluation of the MPCC showed that patients were satisfied with this approach to the complex decision-making process in prostate cancer...
Surgical management of prostate cancer metastatic to the spineBrian J Williams
Department of Neurosurgery, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030 4009, USA
J Neurosurg Spine 10:414-22. 2009..In this study, a series of patients undergoing spinal surgery for metastatic prostate cancer were reviewed to identify predictors of survival and functional outcome...
Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experienceJohn F Anderson
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Urology 74:601-5. 2009..To minimize the risk of long-term urinary morbidity, it is important for clinicians to be able to distinguish acute urinary side effects after prostate brachytherapy from longer-term treatment-related urinary complications...
Is patient age a factor in the occurrence of prostate-specific antigen bounce phenomenon after external beam radiotherapy for prostate cancer?Charles J Rosser
Department of Urology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Urology 66:327-31. 2005..To evaluate the effect of patient age on the occurrence of prostate-specific antigen (PSA) "bounce" after external beam radiotherapy (EBRT) for prostate cancer...
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomyAndrew J Stephenson
Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195 0001, USA
J Clin Oncol 25:2035-41. 2007..We developed a nomogram to predict the probability of cancer control at 6 years after SRT for PSA-defined recurrence...
Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiationCharles J Rosser
Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Cancer Gene Ther 11:273-9. 2004..These findings suggest that overexpression of Bcl-2 result in radioresistance and inability of radiation to cause its typical G2M cell-cycle arrest...
